Supplementary Tables S1-S2 from Prognostic Utility of Anti-EBV Antibody Testing for Defining NPC Risk among Individuals from High-Risk NPC Families

Authors:
  • KYKelly J. Yu
    Kelly J. Yu
  • WHWan-Lun Hsu
    Wan-Lun Hsu
  • RPRuth M. Pfeiffer
    Ruth M. Pfeiffer
  • CCChun-Ju Chiang
    Chun-Ju Chiang
  • CWCheng-Ping Wang
    Cheng-Ping Wang
  • PLPei-Jen Lou
    Pei-Jen Lou
  • YCYu-Juen Cheng
    Yu-Juen Cheng
  • PGPatti Gravitt
    Patti Gravitt
  • SDScott R. Diehl
    Scott R. Diehl
  • AGAlisa M. Goldstein
    Alisa M. Goldstein
  • CCChien-Jen Chen
    Chien-Jen Chen
  • AHAllan Hildesheim
    Allan Hildesheim

Abstract
No abstract available